Has Paul Enker, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,976 in general payments to Paul Enker, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Enker, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Enker, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Enker, MD

Adult Reconstructive Orthopaedic Surgery · Great Neck, NYNPI 1174578132

Payments from drug & device makers

$4,976in general payments, 2019–2025

Across 32 payments — averaging $155.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medacta USA, Inc.$3K
Zimmer Biomet$1K
Stryker$943
Johnson & Johnson$142
Exactech, Inc.$122
Medical Device Business Services, Inc.$81
plus $15 from 1 others

What the payments were for

Travel & lodging$4,03581%
Food & beverage$94119%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medacta USA, Inc.	11	$2,642
Zimmer Biomet	6	$1,033
Stryker	9	$943
Johnson & Johnson	2	$142
Exactech, Inc.	1	$122
Medical Device Business Services, Inc.	2	$81
Convatec Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,976 in reported general payments places this provider in the 25th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$159,593

Medicare patients

326

Services billed

1,081

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol	14	$996
Meloxicam	38	$99
Diclofenac Sodium	13	$83

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Great Neck

Jonathan DanoffGreat Neck$312K
Seth JerabekNew York$7.4M
Jose RodriguezNew York$3.4M
Friedrich BoettnerNew York$2.9M
Jonathan VigdorchikNew York$2.5M
William LongNew York$1.8M
Peter SculcoNew York$1.6M
Herbert CooperNew York$1.5M
Roshan ShahNew York$1.4M
Matthew AustinNew York$1.2M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →